Risk of metabolic syndrome higher with lupus versus the general population
TUESDAY, Sept. 19, 2017 (HealthDay News) — More than one-quarter of patients with systemic lupus erythematosus (SLE) have metabolic syndrome (MetS), according to a review published online Aug. 29 in the International Journal of Rheumatic Diseases.
Chong Sun, from First Hospital of China Medical University in Shenyang, and colleagues conducted a systematic review and meta-analysis assessing the prevalence of MetS in patients with SLE.
The researchers found that 47 studies (8,367 subjects), published between 2006 and 2016, showed a pooled prevalence of MetS in patients with SLE of 0.26. Twenty-four studies (2,744 cases and 3,028 controls) found that SLE patients had high risk of MetS (odds ratio, 1.88).
“The systematic review and meta-analysis demonstrated the prevalence of MetS in patients with SLE was 26 percent and the patients with SLE were more prone to having MetS than the control population,” the authors write.
Abstract
Full Text (subscription or payment may be required)
Copyright © 2017 HealthDay. All rights reserved.
